Clinical Trials Browser

Brain Neoplasms × cabozantinib × 90 days × Clear all

NCT05048212 2026-03-02

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

Phase 2 Recruiting

CNSGenitourinary

Brain Neoplasms, Carcinoma, Renal Cell

NCT01068782 2026-02-25

Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

Phase 2 Terminated

19 enrolled 10 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma